Brief: Grand Pharmaceutical Provides Update On Strategic Investment In Telix
28/02/2025 10:24
Feb 28 (Reuters) - Grand Pharmaceutical Group Ltd 0512.HK: UPDATE ON STRATEGIC INVESTMENT IN TELIX DEAL FOR AU$143 MILLION. DISPOSED 45.2% OF ITS HOLDIN IN TELIX PHARMACEUTICALS INTENTION NOT TO SELL REMAINING TELIX SHARES WITHIN NEXT 12 MONTHS Further company coverage: 0512.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement